Immunoglobulin E-mediated autoimmunity

M Maurer, S Altrichter, O Schmetzer, J Scheffel… - Frontiers in …, 2018 - frontiersin.org
The study of autoimmunity mediated by immunoglobulin E (IgE) autoantibodies, which may
be termed autoallergy, is in its infancy. It is now recognized that systemic lupus …

The role of eosinophils in bullous pemphigoid: a developing model of eosinophil pathogenicity in mucocutaneous disease

KT Amber, M Valdebran, K Kridin, SA Grando - Frontiers in Medicine, 2018 - frontiersin.org
Bullous pemphigoid (BP) is an autoimmune blistering disease which carries a significant
mortality and morbidity. While historically BP has been characterized as an IgG driven …

Bullous pemphigoid: from the clinic to the bench

G Di Zenzo, R Della Torre, G Zambruno… - Clinics in …, 2012 - Elsevier
Bullous pemphigoid (BP) constitutes the most frequent autoimmune subepidermal blistering
disease. It is associated with autoantibodies directed against the BP antigens 180 (BP180 …

IgG4 and IgE are the major immunoglobulins targeting the NC16A domain of BP180 in Bullous pemphigoid: serum levels of these immunoglobulins reflect disease …

R Döpp, E Schmidt, I Chimanovitch, M Leverkus… - Journal of the American …, 2000 - Elsevier
Background: Bullous pemphigoid (BP) is an autoimmune blistering disease associated with
autoantibodies against the hemidesmosomal glycoprotein BP180. The noncollagenous …

Evidence for a role of eosinophils in blister formation in bullous pemphigoid

E de Graauw, C Sitaru, M Horn, L Borradori, S Yousefi… - Allergy, 2017 - Wiley Online Library
Background Bullous pemphigoid (BP) is an autoimmune bullous disease of the skin
characterized by subepidermal blister formation due to tissue‐bound and circulating …

Targeted therapies for autoimmune bullous diseases: current status

KT Amber, R Maglie, F Solimani, R Eming, M Hertl - Drugs, 2018 - Springer
Autoimmune bullous skin disorders are rare but meaningful chronic inflammatory diseases,
many of which had a poor or devastating prognosis prior to the advent of …

Correlation of IgE autoantibody to BP180 with a severe form of bullous pemphigoid

Y Iwata, K Komura, M Kodera, T Usuda… - Archives of …, 2008 - jamanetwork.com
Objective To determine the prevalence, immunoglobulin subclass distribution, and clinical
correlation of antibodies (Abs), especially of IgE Abs, to BP180 and BP230 in patients with …

Mast cells are important modifiers of autoimmune disease: with so much evidence, why is there still controversy?

MA Brown, JK Hatfield - Frontiers in immunology, 2012 - frontiersin.org
There is abundant evidence that mast cells are active participants in events that mediate
tissue damage in autoimmune disease. Disease-associated increases in mast cell numbers …

IgE-mediated mechanisms in bullous pemphigoid and other autoimmune bullous diseases

N Van Beek, FS Schulze, D Zillikens… - Expert review of clinical …, 2016 - Taylor & Francis
Autoimmune bullous diseases (AIBDs) are characterized by autoantibodies against
structural proteins of the dermal–epidermal junction (in pemphigoid diseases) and the …

Linking allergy to autoimmune disease

R Valenta, I Mittermann, T Werfel, H Garn, H Renz - Trends in immunology, 2009 - cell.com
Type I allergy is a classical Th2-driven hypersensitivity disease based on IgE recognition of
environmental allergens. Exposure of allergic individuals to exogenous allergens leads to …